Our findings highlight the crucial roles of CHOP and R-CHOP, either using alone or in combination with GM-CSF, on the re-polarization of tumor-associated macrophages in DLBCL, thus providing an optimizing strategy for CHOP-based DLBCL treatment. The gene discussed is DDIT3; the disease is neoplasm.